There is considerable excitement surrounding the treatment potential of T cell immunotherapies. Amongst these, CAR-T cells have demonstrated impressive therapeutic efficacy in a subset of ...
The advanced air mobility (AAM) market is gaining traction to transform the transportation of goods and people. While OEMs have focused on design and certification, supply chains have been left to ...
FOYE recognizes that advancing industrial automation does not mean replacing pneumatic technology, but elevating it. By improving precision, standardization, and compatibility, pneumatic components ...
As part of the EU-funded Clean Sky 2/Clean Aviation project “Large Passenger Aircraft” (“LPA”), the Fraunhofer-Gesellschaft in Stade, Germany, together with international project partners, has joined ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, ...
Patented multi-blade technology and parallel high-speed transport systems ensure precision, reliability and high-volume razor ...
Those who have always dreamed of working with robots, enjoy computers, or simply want to further their career possibilities are training to meet Birmingham's automated manufacturing needs.Automated ...
SOUTH SAN FRANCISCO, Calif., Sept. 11, 2023 /PRNewswire/ -- Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy ...
The DIKUQ project has developed a semi-automated process chain for forming steel sheets for shipbuilding. Fraunhofer IOF designed a novel inline 3D measurement system that can digitally capture ...
The DLR Center for Lightweight Production Technology (ZLP) has demonstrated an automated process for an A350 rear pressure bulkhead (RPB) using dry CF fabric (left) and resin infusion with Hexcel’s ...
Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a collaboration with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford ...
Collaboration with intent to validate Cellares’ Cell Shuttle platform for manufacturing of CABA-201, Cabaletta Bio’s fully human CD19-CAR T product candidate, which is being evaluated in parallel ...